.
RSO financial statements
* Numbers in millions
| Capitalization * | 28 731 |
|---|---|
| EV * | 31 812 |
| Number of shares * | 352 |
| EPS | 0,24 |
| Revenue * | 12 532 |
| Net income * | 85 |
| Operating profit * | 190 |
| Total liabilities * | 9 427 |
| Net debt * | -2 306 |
| Total assets * | 12 718 |
| Equity * | 3 291 |
| Cash and investments * | 4 819 |
.
RSO valuation
| P/E | 336,49 |
|---|---|
| P/B | 8,73 |
| P/S | 2,29 |
| E/P | 0 |
| P/FCF | 15,61 |
.
RSO profitability
| ROE | 3% |
|---|---|
| ROA% | 1% |
| ROIC% | 2% |